Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer
-
AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer
-
H1 2016 Results
-
AstraZeneca files first clinical trial application in Moderna messenger RNA collaboration
-
AstraZeneca’s antibiotic Zavicefta met primary endpoints in Phase III trial for treatment of hospital-acquired pneumonia
-
AstraZeneca receives approval in the EU for Qtern (saxagliptin and dapagliflozin) for treatment of Type 2 diabetes
-
AstraZeneca Receives Approval In The Eu For Qtern (Saxagliptin And Dapagliflozin) For Treatment Of Type 2 Diabetes
-
Tagrisso met primary endpoint in phase III 2nd-line lung cancer trial
-
AstraZeneca enters licensing agreements with LEO Pharma in skin diseases
-
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
